Profile data is unavailable for this security.
About the company
Herbalife Ltd. is a global nutrition company. The Company sells weight management; targeted nutrition; energy, sports and fitness; and other nutrition products to and through a network of independent members (Members). Its products include meal replacements, protein shakes, teas, aloes, high-protein snacks, vitamins and supplements, sports nutrition and outer nutrition products. The Company offers a range of meal replacement products, such as protein shakes, bars and soups. Its snack portfolio includes a variety of sweet, savory and creamy options, such as high protein iced coffee, protein bars, snack shakes, soups, baking mixes and others. Its Herbal Aloe Concentrate is a beverage formulated with aloe vera, which can be mixed with water, tea or protein shake. It has also developed a portfolio of dietary supplements, encompassing solutions for heart health, digestive health, immunity and others. It sells products in 95 markets across the world.
- Revenue in USD (TTM)5.07bn
- Net income in USD137.20m
- Incorporated2002
- Employees9.20k
- LocationHerbalife LtdUgland House, South Church StreetP.O. Box 309GtGRAND CAYMAN 00000Cayman IslandsCYM
- Phone+1 3453 104109600
- Fax+1 3 102587019
- Websitehttps://www.herbalife.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nu Skin Enterprises, Inc. | 1.97bn | 8.60m | 634.71m | 3.70k | 78.80 | 0.7696 | 7.98 | 0.3223 | 0.1622 | 0.1622 | 38.97 | 16.61 | 1.09 | 1.95 | 32.75 | 532,197.60 | 0.4739 | 6.80 | 0.5848 | 8.90 | 68.93 | 73.45 | 0.4365 | 5.26 | 1.28 | -- | 0.3797 | 62.58 | -11.53 | -5.97 | -91.80 | -41.16 | -3.63 | 1.33 |
YSB Inc | 2.35bn | -441.63m | 679.91m | 6.31k | -- | 2.56 | -- | 0.2893 | -25.68 | -25.68 | 47.57 | 3.24 | -- | -- | -- | 2,912,343.00 | -- | -- | -- | -- | 10.26 | -- | -18.89 | -- | 1.01 | -- | 0.1002 | -- | 18.90 | -- | -114.23 | -- | -- | -- |
Uniphar PLC | 2.75bn | 48.32m | 765.35m | 3.26k | 15.84 | 2.13 | 8.81 | 0.278 | 0.1641 | 0.1641 | 9.35 | 1.22 | 2.13 | 12.64 | 12.71 | 782,667.70 | 3.76 | 4.12 | 6.49 | 7.24 | 15.28 | 13.61 | 1.77 | 1.87 | 0.5634 | 3.22 | 0.5338 | 10.93 | 23.30 | 12.48 | -1.69 | 38.98 | 45.53 | -- |
NanJing Pharmaceutical Co Ltd | 7.40bn | 81.39m | 894.49m | 4.90k | 11.06 | 0.9693 | -- | 0.1208 | 0.4457 | 0.4457 | 40.51 | 5.09 | 1.63 | 8.33 | 3.33 | 10,903,610.00 | 2.22 | 2.32 | 7.44 | 8.94 | 6.04 | 6.41 | 1.36 | 1.30 | 1.13 | 2.91 | 0.6359 | 29.82 | 6.71 | 11.35 | -3.00 | 16.93 | -12.67 | 9.86 |
Selcuk Ecza Deposu Ticaret ve Sanayi AS | 3.03bn | 6.92m | 988.76m | 6.03k | 142.86 | 2.12 | 49.78 | 0.3263 | 0.3594 | 0.3594 | 157.36 | 24.25 | 2.30 | 10.73 | 10.42 | 16,218,930.00 | 0.5255 | 3.16 | 1.41 | 8.40 | 9.38 | 9.37 | 0.2284 | 1.24 | 1.05 | -- | 0.1382 | 27.16 | 14.70 | 48.64 | -64.89 | -10.62 | 23.13 | 20.11 |
Neuca SA | 2.97bn | 36.78m | 1.02bn | 5.19k | 28.44 | 4.10 | 14.87 | 0.345 | 32.42 | 32.42 | 2,617.05 | 224.63 | 2.38 | 7.47 | 7.13 | 2,276,477.00 | 3.21 | 3.58 | 12.45 | 13.31 | 11.07 | 10.33 | 1.35 | 1.43 | 0.4725 | 4.33 | 0.3336 | 34.59 | 5.17 | 8.79 | 6.58 | 8.95 | -3.07 | -- |
Herbalife Ltd | 5.07bn | 137.20m | 1.06bn | 9.20k | 7.72 | -- | 4.20 | 0.2084 | 1.37 | 1.37 | 50.57 | -10.39 | 1.90 | 2.25 | 58.67 | 551,586.90 | 5.14 | 11.30 | 8.68 | 18.70 | 76.80 | 78.43 | 2.70 | 6.02 | 0.7667 | 2.98 | 1.76 | 0.00 | -2.73 | 0.688 | -55.74 | -13.67 | 9.95 | -- |
DocMorris AG | 1.07bn | -129.76m | 1.19bn | 1.45k | -- | 2.05 | -- | 1.12 | -10.07 | 7.03 | 83.05 | 36.60 | 0.9863 | 11.36 | 10.50 | 667,214.10 | -11.96 | -12.92 | -15.23 | -15.74 | 20.98 | 16.84 | -12.13 | -10.87 | 1.34 | -2.39 | 0.4448 | -- | 4.13 | -4.29 | 31.29 | -- | -2.53 | -- |
Guangxi LiuYao Group Co Ltd | 2.94bn | 123.09m | 1.28bn | 5.58k | 9.44 | 1.21 | -- | 0.436 | 2.46 | 2.46 | 58.82 | 19.12 | 1.07 | 6.99 | 1.97 | 3,807,204.00 | 4.80 | 5.06 | 11.73 | 12.21 | 11.56 | 11.85 | 4.47 | 4.40 | 1.30 | 5.26 | 0.5434 | 29.90 | 9.23 | 12.18 | 21.11 | 9.97 | -8.63 | 6.26 |
Sigma Healthcare Ltd | 2.26bn | 2.98m | 1.39bn | 156.00 | 325.32 | 2.32 | 62.35 | 0.6136 | 0.004 | 0.004 | 3.34 | 0.5544 | 2.68 | 11.37 | 10.52 | -- | 0.4162 | 0.5734 | 0.625 | 0.9762 | 9.17 | 9.52 | 0.1554 | 0.2022 | 1.86 | 1.59 | 0.1354 | 184.52 | -9.16 | -3.46 | 148.98 | -34.19 | -46.55 | -21.93 |
Holder | Shares | % Held |
---|---|---|
Route One Investment Co. LPas of 31 Dec 2023 | 10.31m | 10.39% |
The Vanguard Group, Inc.as of 31 Dec 2023 | 10.01m | 10.08% |
The WindAcre Partnership LLCas of 31 Dec 2023 | 8.90m | 8.97% |
BlackRock Fund Advisorsas of 31 Dec 2023 | 6.57m | 6.61% |
Morgan Stanley & Co. LLCas of 31 Dec 2023 | 6.44m | 6.49% |
Renaissance Technologies LLCas of 31 Dec 2023 | 5.93m | 5.97% |
SSgA Funds Management, Inc.as of 31 Dec 2023 | 4.62m | 4.65% |
UBS Securities LLCas of 31 Dec 2023 | 3.68m | 3.70% |
Bronte Capital Management Pty Ltd.as of 31 Dec 2023 | 3.10m | 3.13% |
Geode Capital Management LLCas of 31 Dec 2023 | 2.26m | 2.27% |